n 0437, (-)-isomer has been researched along with Movement Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, S; Madokoro, Y; Matsukawa, N; Mizuno, M; Okita, K | 1 |
| Boroojerdi, B; Fichtner, A; Giladi, N; Poewe, W | 1 |
| Caputi, C; Galosi, S; Giannini, MT; Leuzzi, V; Mastrangelo, M | 1 |
| Behrens, S; Sommerville, K | 1 |
| Jankovic, J | 1 |
1 review(s) available for n 0437, (-)-isomer and Movement Disorders
| Article | Year |
|---|---|
Parkinson's disease and movement disorders: moving forward.
Topics: Dopamine Agonists; Humans; Methyldopa; Movement Disorders; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2008 |
1 trial(s) available for n 0437, (-)-isomer and Movement Disorders
| Article | Year |
|---|---|
Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.
Topics: Aged; Dopamine Agonists; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies; Sleep Wake Disorders; Tetrahydronaphthalenes; Thiophenes | 2010 |
3 other study(ies) available for n 0437, (-)-isomer and Movement Disorders
| Article | Year |
|---|---|
Painful legs and moving toes syndrome associated with dementia with Lewy bodies responsive to rotigotine-induced analgesia.
Topics: Analgesia; Humans; Leg; Lewy Body Disease; Movement Disorders; Pain; Peripheral Nervous System Diseases; Restless Legs Syndrome; Toes | 2022 |
Transdermal rotigotine in the treatment of aromatic L-amino acid decarboxylase deficiency.
Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Aromatic-L-Amino-Acid Decarboxylases; Child; Dopamine Agonists; Humans; Male; Movement Disorders; Tetrahydronaphthalenes; Thiophenes; Treatment Outcome | 2013 |
Non-oral drug delivery in Parkinson's disease: a summary from the symposium at the 7th International Congress of Parkinson's Disease and Movement Disorders. 10-14 November 2002, Miami, FL, USA.
Topics: Antiparkinson Agents; Congresses as Topic; Humans; Intestinal Absorption; Levodopa; Movement Disorders; Parkinson Disease; Tetrahydronaphthalenes; Thiophenes | 2003 |